These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 2501941

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Microsomal metabolism of the carcinogen, N-2-fluorenyl-acetamide, by the mammary gland and liver of female rats. II. Glucuronidation of ring- and N-hydroxylated metabolites of N-2-fluorenylacetamide.
    Malejka-Giganti D, Ryzewski CN.
    Carcinogenesis; 1985 May; 6(5):687-92. PubMed ID: 3924428
    [Abstract] [Full Text] [Related]

  • 4. Sex hormone-mediated effects on the phase I and phase II metabolism of N-2-fluorenylacetamide. Modulation of 9-hydroxylation.
    Malejka-Giganti D, Magat WJ, Decker RW.
    Biochem Pharmacol; 1989 Apr 01; 38(7):1075-82. PubMed ID: 2495797
    [Abstract] [Full Text] [Related]

  • 5. Modifications of carcinogen metabolism in hepatic microsomes of suckling young by 3-methylcholanthrene or beta-naphthoflavone administered to lactating rats.
    Malejka-Giganti D, Decker RW, Ritter CL.
    Biochem Pharmacol; 1983 Nov 15; 32(22):3335-44. PubMed ID: 6316979
    [Abstract] [Full Text] [Related]

  • 6. Effects of acute or chronic treatment of rats with N-2-fluorenylacetamide on its N-hydroxylation and on hemoproteins of hepatic microsomes.
    Malejka-Giganti D, Ritter CL.
    Res Commun Chem Pathol Pharmacol; 1980 Apr 15; 28(1):53-64. PubMed ID: 7394317
    [Abstract] [Full Text] [Related]

  • 7. Aryl sulfotransferase IV deficiency in rat liver carcinogenesis initiated with diethylnitrosamine and promoted with N-2-fluorenylacetamide or its C-9-oxidized metabolites.
    Malejka-Giganti D, Ringer DP, Vijayaraghavan P, Kiehlbauch CC, Kong J.
    Exp Mol Pathol; 1997 Apr 15; 64(2):63-77. PubMed ID: 9316585
    [Abstract] [Full Text] [Related]

  • 8. Inhibitory effect of disulfiram on rat mammary tumor induction by N-2-fluorenylacetamide and on its metabolic conversion to N-hydroxy-N-2-fluorenylacetamide.
    Malejka-Giganti D, McIver RC, Rydell RE.
    J Natl Cancer Inst; 1980 Jun 15; 64(6):1471-7. PubMed ID: 6929383
    [Abstract] [Full Text] [Related]

  • 9. Comparative in vitro metabolism of T-2 toxin by hepatic microsomes prepared from phenobarbital-induced or control rats, mice, rabbits and chickens.
    Knupp CA, Swanson SP, Buck WB.
    Food Chem Toxicol; 1987 Nov 15; 25(11):859-65. PubMed ID: 3692389
    [Abstract] [Full Text] [Related]

  • 10. Microsomal metabolism of arylamides by the rat and guinea pig--I. Oxidation of N-3-fluorenylacetamide at carbon-atom-9--a major metabolic reaction.
    Kaplan E, Gutmann HR, Emory TH.
    Biochem Pharmacol; 1978 Nov 15; 27(11):1581-9. PubMed ID: 697900
    [No Abstract] [Full Text] [Related]

  • 11. Additional routes in the metabolism of phenacetin.
    Fischbach T, Lenk W.
    Xenobiotica; 1985 Feb 15; 15(2):149-64. PubMed ID: 4002737
    [Abstract] [Full Text] [Related]

  • 12. Early stages of N-2-fluorenylacetamide-induced hepatocarcinogenesis in male and female rats and effect of gonadectomy on liver neoplastic conversion and neoplastic development.
    Katayama S, Ohmori T, Maeura Y, Croci T, Williams GM.
    J Natl Cancer Inst; 1984 Jul 15; 73(1):141-9. PubMed ID: 6588222
    [Abstract] [Full Text] [Related]

  • 13. Effects of phenobarbital, dexamethasone, and 3-methylcholanthrene administration on the metabolism of 17 beta-estradiol by liver microsomes from female rats.
    Suchar LA, Chang RL, Thomas PE, Rosen RT, Lech J, Conney AH.
    Endocrinology; 1996 Feb 15; 137(2):663-76. PubMed ID: 8593816
    [Abstract] [Full Text] [Related]

  • 14. Mammary carcinogenesis in the rat by topical application of fluorenylhydroxamic acids and their acetates.
    Malejka-Giganti D, Rydell RE, Gutmann HR.
    Cancer Res; 1977 Jan 15; 37(1):111-7. PubMed ID: 830400
    [Abstract] [Full Text] [Related]

  • 15. Metabolism of 2-acetylaminofluorene. I. Metabolism in vitro of 2-acetylaminofluorene and 2-acetylaminofluoren-9-one by hepatic enzymes.
    Lenk W, Rosenbauer-Thilmann R.
    Xenobiotica; 1993 Mar 15; 23(3):241-57. PubMed ID: 8498087
    [Abstract] [Full Text] [Related]

  • 16. Influences of different polychlorinated biphenyls on cytocidal, mitoinhibitory, and nodule-selecting activities of N-2-fluorenylacetamide in rat liver.
    Hayes MA, Roberts E, Safe SH, Farber E, Cameron RG.
    J Natl Cancer Inst; 1986 Apr 15; 76(4):683-91. PubMed ID: 2870208
    [Abstract] [Full Text] [Related]

  • 17. Aminopyrine metabolism by multiple forms of cytochrome P-450 from rat liver microsomes: simultaneous quantitation of four aminopyrine metabolites by high-performance liquid chromatography.
    Imaoka S, Inoue K, Funae Y.
    Arch Biochem Biophys; 1988 Aug 15; 265(1):159-70. PubMed ID: 3415241
    [Abstract] [Full Text] [Related]

  • 18. Qualitative and quantitative differences in the induction and inhibition of hepatic benzo[a]pyrene metabolism in the rat and hamster.
    Wroblewski VJ, Gessner T, Olson JR.
    Biochem Pharmacol; 1988 Apr 15; 37(8):1509-17. PubMed ID: 3358781
    [Abstract] [Full Text] [Related]

  • 19. Effect of the structural isomer N-3-fluorenylacetamide on microsomal binding and hydroxylation of the carcinogen N-2-fluorenylacetamide.
    Chow YM, Gutmann HR, Kaplan E.
    Biochem Pharmacol; 1981 Jun 01; 30(11):1253-61. PubMed ID: 7271824
    [No Abstract] [Full Text] [Related]

  • 20. Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated rats.
    Jeffery EH, Mannering GJ.
    Mol Pharmacol; 1983 May 01; 23(3):748-57. PubMed ID: 6865917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.